Centiva Capital, LP Abb Vie Inc. Call Options Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $3.6 Million - $4.1 Million	-22,500 Reduced 81.82%	5,000 $910,000
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $2.34 Million - $2.63 Million	-17,000 Reduced 38.2%	27,500 $4.26 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $1.32 Million - $1.53 Million	9,900 Added 28.61%	44,500 $6.63 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $2.24 Million - $2.79 Million	-16,900 Reduced 32.82%	34,600 $4.66 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $1.87 Million - $2.15 Million	-12,900 Reduced 20.03%	51,500 $8.21 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $110,648 - $132,696	-800 Reduced 1.23%	64,400 $10.4 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $2.42 Million - $2.77 Million	18,000 Added 38.14%	65,200 $8.75 Million
Q2 2022 Aug 17, 2022	BUY	$137.62 - $174.96 $3.66 Million - $4.65 Million	26,600 Added 129.13%	47,200 $7.23 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $2.76 Million - $3.42 Million	-20,900 Reduced 50.36%	20,600 $3.34 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $4.07 Million - $5.14 Million	37,850 Added 1036.99%	41,500 $5.62 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $335,160 - $380,457	3,150 Added 630.0%	3,650 $394,000
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $102,718 - $137,452	-1,400 Reduced 73.68%	500 $49,000
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $5.73 Million - $8.68 Million	-88,800 Reduced 97.91%	1,900 $144,000
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $2.26 Million - $2.83 Million	31,400 Added 52.95%	90,700 $8.03 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $2.44 Million - $2.93 Million	38,700 Added 187.86%	59,300 $4.49 Million
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $2.08 Million - $2.66 Million	-31,700 Reduced 60.61%	20,600 $1.5 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $1.73 Million - $2.03 Million	-22,400 Reduced 29.99%	52,300 $4.21 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $2.32 Million - $2.86 Million	29,800 Added 66.37%	74,700 $6.89 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $3.99 Million - $4.44 Million	44,900 New	44,900 $4.25 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account